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ABSTRACT: Gold nanoparticles have been conceived as a radiosensitizer in cancer radiation therapy, 
but one of the important questions for primary drug screening is what size of gold nanoparticles can 
optimally enhance radiation effects. Herein, we perform in vitro and in vivo radiosensitization studies of 
4.8, 12.1, 27.3, and 46.6 nm PEG-coated gold nanoparticles. In vitro results show that all sizes of the 
PEG-coated gold nanoparticles can cause a significant decrease in cancer cell survival after gamma 
radiation. 12.1 and 27.3 nm PEG-coated gold nanoparticles have dispersive distributions in the cells and 
have stronger sensitization effects than 4.8 and 46.6 nm particles by both cell apoptosis and necrosis. 
Further, in vivo results also show all sizes of the PEG-coated gold nanoparticles can decrease tumor 
volume and weight after 5 Gy radiations, and 12.1 and 27.3 nm PEG-coated gold nanoparticles have 
greater sensitization effects than 4.8 and 46.6 nm particles, which can lead to almost complete 
disappearance of the tumor. In vivo biodistribution confirms that 12.1 and 27.3 nm PEG-coated gold 
nanoparticles are accumulated in the tumor with high concentrations. The pathology, immune response, 
and blood biochemistry indicate that the PEG-coated gold nanoparticles don’t cause spleen and kidney 
damages, but give rise to liver damage and gold accumulation. It can be concluded that 12.1 and 27.3 
nm PEG-coated gold nanoparticles show high radiosensitivity, and these results have an important 
indication for possible radiotherapy and drug delivery. 
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1. Introduction 
Gold nanoparticles (NPs) have wide 
biomedical applications because of their unique 
surface chemistry, electronic, and optical 
properties [1-2]. Today, gold NPs have been 
conceived as a kind of radiosensitizer in 
radiotherapy. This is because the strong 
photoelectric absorption and secondary electron 
caused by gamma or X-ray irradiation can 
accelerate DNA strand break [3-4]. The biosafety 
of metallic gold is good and it has been used 
since the 1950s. In vitro and in vivo 
biocompatibilities of gold NPs have been widely 
investigated in recent years [5-6]. The toxicity of 
gold NPs can be determined by size, shape, 
surface charge, and surface coating, but the 
overall toxicity dose of gold NPs is in an 
acceptable level [7-12]. This makes the 
applications of gold NPs in cancer radiation 
therapy possible. 
In general, the photoelectric absorption cross 
sections of radiosensitive materials directly 
depend on atom radius [13], and thus their 
radiotherapy effects also depend on atom radius 
[14-17]. This physical principle determines that 
gold (atomic-number Z=79) has a stronger 
radiation enhancement effect by photoelectric 
effect than other radiosensitive materials such as 
carbon (Z=6), iodine (Z = 53), gadolinium (Z = 
64), and platinum (Z =78). Gold NPs have a 
larger atomic radius than gold atom (~0.17 nm), 
and thus should have a stronger radiation 
enhancement effect than gold atom. Further, in 
theory, the enhanced effect of gold NPs in 
radiotherapy should be size-dependent, namely 
the larger, the better. However, the real situation 
is complex. 
In vivo experimental data showed that small 
gold NPs of 1.9 nm could effectively enhance 
radiotherapy [3, 18]. Subsequently, in vitro 
investigation showed that the PEG-coated gold 
NPs of 4.6 and 6.1 nm could decrease the cell 
survival rates of both EMT-6 and CT26 [19]. 
Typical 10 nm gold NPs coated with cysteamine 
and glucose had a significant radiation sensitivity 
to all high energy rays, with 200 keV being 
preferred [20]. However, it was surprising that 
gold NPs in the size range 5-10 nm were not 
found to be more efficient in enhancement of 
radiation sensitivity as compared with the ultra 
small 1.9 nm gold particles [21]. In other work, it 
was found that 50 nm naked gold NPs have a 
stronger radiation sensitivity than 14 and 74 nm 
gold particles. This was because 50 nm naked 
gold particles had the greatest endocytosis and 
cellar uptake [4, 22]. However, it is well known 
that physiological pH citrate coated gold NPs 
have a high zeta potential, and the particles tend 
to aggregate severely [23]. Therapeutic gold NPs 
smaller than 50 nm can easily pass through cell 
membrane, and particles smaller than 20 nm can 
pass through blood vessel endothelium [24].  
Meanwhile, the surface coating, such as PEG-SH, 
can improve the stability of gold NPs [25-26]. 
Therefore, it is desirable to clarify the size-
dependent radiosensitization effects of 5-60 nm 
PEG-coated gold NPs. This has a significant 
indication on the effectiveness of both 
radiotherapy and drug delivery. 
Here, we address in vitro and in vivo size-
dependent enhancement of radiation effects of 
gold NPs. PEG-SH, widely used as coating 
material, was chosen as the surface coating to 
improve the monodispersity and biocompatibility 
of gold NPs. We carried out the radiosensitization 
studies of 4.8, 12.1, 27.3, and 46.6 nm PEG-
coated gold NPs in HeLa cells. The toxicities of 
the PEG-coated gold NPs with different sizes 
were analyzed after 24 and 48 hours treatments. 
Cloning formation and cell apoptosis were used 
to evaluate the enhancement of radiation effects. 
Subsequently, in vivo radiosensitization effects of 
4.8, 12.1, 27.3, and 46.6 nm PEG-coated gold 
particles were studied by evaluating tumor size 
and weight after 5 Gy gamma radiations. The 
pathology, biochemistry, organ index, and 
distribution were used to evaluate the toxicities of 
these PEG-coated gold NPs. These experimental 
results will clarify what size of gold particles is 
suitable for radiotherapy and related medical 
treatments. 
2. Materials and methods 
2.1. Fabrication and stability of the PEG-coated 
gold NPs  
Gold NPs were fabricated following the 
classical method introduced by Turkevich. 100 
mL  0.01% chlorauric acid (HAuCl4·4H2O) 
solution was refluxed, and 0.8, 1.3, and 5 mL 1% 
sodium citrate solution was added respectively to 
the boiling solution for obtaining NPs with 
different sizes. The reduction of gold ions by the 
citrate ions was completed after 5 min. The 
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solution was further boiled for 30 min, and then 
left to cool at room temperature. The small size 
gold NPs were reduced by NaBH4. Subsequently, 
1 mg PEG-SH (5000 MW, Sigma) was mixed 
with gold NPs and stirred for 1 h to covalently 
modify the surface of the gold NPs with PEG[2]. 
The resulting PEG-coated gold NPs were 
collected by centrifugation at 16,000 rpm for 30 
min and washed twice with distilled water. The 
PEG-coated gold NPs solution was stored at 4 ℃ 
in order to prevent aggravations. 
Zeta (ζ) potential for gold NPs was determined 
with the NanoZS Zetasizer particle analyzer 
(Malvern Instruments, Ltd., Malvern, UK). Data 
were acquired in the phase analysis light 
scattering mode at 25 °C, and sample solutions 
were prepared by diluting gold NPs into 10 mM 
phosphate-buffered saline (PBS) solution (pH 
7.0). Stability of gold NPs was evaluated using 
optical absorption. Gold NPs were diluted five 
times in human blood plasma, and optical 
absorption spectra were measured at the time 
points of 0.5, 1, 2, 6, 12, and 24 hours using a 
UV-vis spectrophotometer (DU800) in a 5 ml 
glass cuvette. The size and morphology of gold 
NPs were analyzed by transmission electron 
microscopy (TEM) using a Hitachi HF-2000 field 
emission high-resolution TEM operating at 200 
kV. 
2.2. Cell culture and viability assay 
HeLa cells were cultured in low-glucose 
DMEM. Media contained fetal calf serum (10 %), 
L-glutamine (2.9 mg/mL), streptomycin (1 
mg/mL), and penicillin (1000 units/mL) at 37 °C 
in humidified atmosphere with 5% CO2. The cells 
(in culture medium) were dispensed in 96-well 
plates (90 mL in each well containing 104 cells). 
10 μL PEG-coated gold NPs were dissolved in 
culture medium, and then 100 μL blendings were 
added to each well with different concentrations 
(0.001-025 mM). The concentration effect of the 
PEG-coated gold NPs was assessed using Cell 
Titre-Glo™ luminescent cell viability assay 
(Promega, Madison, WI, USA) after 24 and 48 
hours treatments. This assay was a homogenous 
method of determining the number of viable cells 
in culture based on the quantitation of adenosine 
triphosphate (ATP), which signaled the presence 
of metabolically active cells. After the treatment, 
the cells were incubated with 20 μL of Cell Titre-
Glo™ reagent and contents were allowed to mix 
on an orbital shaker in accordance with the assay 
protocols, which resulted in cell lysis and 
generation of a luminescent signal proportional to 
the amount of ATP present. The amount of ATP 
was proportional to the number of cells presented 
in culture. The luminescence signal was recorded 
with a single tube luminometer (TD 20/20, 
Turner Biosystems Inc., Sunnyvale, CA, USA). 
A four-parameter logistic model was used to 
evaluate half maximal inhibitory concentration 
(IC50) of gold NPs. For each size of the PEG-
coated gold NPs, IC50 value was determined from 
triplicate wells during both the stationary and 
logarithmic cell growth phases. IC50 value 
obtained from logarithmic cell growth was 
routinely repeated in three independent 
experiments. 
2.3. Colony formation assay 
HeLa cells were incubated in 25 cm2 flasks 
overnight and then exposed to the PEG-coated 
gold NPs at the concentrations of 0.05 and 0.1 
mM. Gold NPs were administrated 24 hours 
before irradiation. The cells were irradiated by 
137Cs with activity of 3600 Ci and photon energy 
of 662 KeV at doses of 1, 2, 4, 6, and 8 Gy, 
respectively. After irradiation, HeLa cells were 
trypsinized, counted, and seeded in 6 cm dishes 
with 5 mL medium at appropriate concentrations. 
There were six dishes for each dose. The cells 
were incubated for 10 days and then stained with 
crystal violet. The colonies formations were fixed 
and the surviving fraction was determined by the 
proportion of seeded cells following irradiation to 
form colonies relative to untreated cells as 
described. Colonies with more than 50 cells were 
counted. The cell survival curve was estimated by 
a multitarget single-hit model 
( NDDeS )1(1 0−−= ) (L-Q) and then  was 
calculated, where S is the surviving fraction and 
D is the radiation dose [27]. The sensitization 
enhancement ratio (SER) was determined by ratio 
of radiation dose that resulted in 50% survival of 
the cells. 
0D
2.4. Cell apoptosis 
To measure apoptosis, HeLa cells were 
incubated for 72 hours at 37 ℃ with 5% CO2. 
Then 0.1 mM PEG-coated gold NPs with 
different sizes were added and then radiated by 2 
Gy gamma rays. Annexin V binding was 
performed using an AnnexinV-FITC kit (BD 
company, US) with the method described by the 
manufacturer. The cells were washed twice with 
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cold phosphate-buffered saline and were then 
resuspended in 1× binding buffer at the 
concentration of 1 × 106 cells/mL. After this, 100 
μL of solution (1 × 105 cells) was transferred to a 
5 mL culture tube. Annexın V-FITC 5 μL and 
propidium iodide 5 μL were added, and the cells 
were then incubated for 15 minutes at room 
temperature in the dark, after which 400 μL 1× 
binding buffer was added to each tube and 
analyzed in the FACS. 
2.5. Microscopic properties of gold NPs  
For the TEM analysis, samples were prepared 
in dimethyl sulfoxide. The cells were deposited 
on Formvar-coated 200–300 mesh copper grids 
and dried, fixed with 2.5% glutaraldehyde in 0.1 
M phosphate buffer (pH 7.4), and left in 
phosphate-buffer for 2 hours. The cells were 
transferred onto 200-mesh uncoated copper grids, 
and were observed with a Hitachi HF-2000 field 
emission high-resolution TEM operating at 200 
kV. 
2.6. Animal model and treatment 
All animals were purchased, maintained, and 
handled using protocols approved by the Institute 
of Radiation Medicine at the Chinese Academy 
of Medical Sciences (CAMS). The U14 tumor 
models were generated by subcutaneous injection 
of 2×106 cells in 50 μL PBS into the right 
shoulder of female BALB/c mice. The mice were 
treated with the PEG-coated gold NPs when the 
tumor volume reached 50 to 100 mm3 (6 days 
after tumor inoculation). For the treatment, 100 
μL 4.8, 12.1, 27.3, and 46.6 nm PEG-coated gold 
NPs and saline were injected into mice via 
intraperitoneal injection. Subsequently, the mice 
were radiated by 5 Gy gamma rays. 80 mice were 
assigned to following groups (eight mice in each 
group): control, 4.8 nm, 12.1 nm, 27.3 nm, 46.6 
nm, radiation alone, 4.8 nm + radiation, 12.1 nm 
+  radiation, 27.3 nm + radiation, and 46.6 nm + 
radiation groups. The injected doses were 
normalized to be about 4 mg/kg PEG-coated gold 
NPs. The tumors sizes were measured every two 
or three days and calculated as: volume = (tumor 
length) × (tumor width)2/2. 
2.7. Pathology, immune response, and 
biochemistry  
After 24 days treatment, all mice were 
sacrificed and blood was collected for 
biochemistry and organ studies. Mice were 
sacrificed using isoflurane anesthetic and 
angiocatheter exsanguination with phosphate-
buffered saline. One mouse from each group was 
fixed with 10% buffered formalin following 
phosphate-buffered saline exsanguination. During 
necropsy, liver, kidneys, spleen, heart, and 
thyroid were collected and weighed. The liver, 
kidneys, spleen, bone marrow, and lymph nodes 
were sectioned from the fixed mice. To explicitly 
examine the grade of changes caused by malities, 
spleen and thymus indexes ( ) can be defined as: xS
)( animalalexperimentofWeight
)(organ alexperimentofWeight
S
g
mg
x =  
Mice were weighed and assessed for behavioral 
changes. Using a standard saphenous vein blood 
collection technique, blood was drawn for 
hematology analysis (potassium EDTA collection 
tube) and serum biochemistry analysis 
(lithiumheparin collection tube). Major organs 
from those mice were harvested, fixed in 4% 
neutral buffered formalin, processed routinely 
into paraffin, and stained with hematoxylin and 
eosin (H&E). Pathology was examined using a 
digital microscope. Bone marrow and blood cells 
were obtained after intraperitoneal injection of 24 
days at the dose of 4 mg/ml, and were observed 
with a Hitachi HF-2000 field emission high-
resolution TEM operating at 200 kV. 
2.8. Statistical analyses 
All data presented are the average ± SD of 
experiments repeated three or more times. The 
paired Student's t-test was used for statistical 
analysis of luciferase reporter assay and 
clonogenic assay using Statistical Analysis 
System (SAS) software. 
3. Results and discussions  
3.1. Fabrication and properties of the PEG-
coated gold NPs  
The size distribution and optical absorption of 
the PEG-coated gold NPs are characterized by 
TEM and spectrophotometer in Fig.1. The 
average sizes of the PEG-coated gold NPs are 
about 4.8, 12.1, 27.3, and 46.6 nm respectively, 
which are similar to the previous reported results 
[1-12]. The surface plasmon resonance (SPR) has 
been observed for all sizes of the PEG-coated 
gold NPs by using optical absorption, and they 
are located at 516, 522, 526, and 535 nm, 
corresponding to 4.8, 12.1, 27.3, 46.6 nm PEG-
coated gold NPs, respectively. It is well known 
that SPR peak is closely related to medium and 
physical dimensions, and the increase of size can 
induce the redshift of SPR. Mie theory can well 
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describe the size-related SPR shift by 
electromagnetic interaction between gold NPs 
and incident light [28]. Besides, surface chemical 
activity can be modified by adding PEG coating. 
We find that the ζ potentials of 4.8, 12.1, 27.3, 
and 46.6 nm naked gold particles are -22.1, -
18.23, -16.7, and -10.27 mV, respectively, and 
these high ζ potentials are due to citric acid 
coating and negative charge in the surface. 
However, PEG-SH coating induces the decreases 
of ζ potentials to -6.96, -2.55, -2.097, and -1.065 
mV, respectively. 
 
Figure 1. (a) TEM image and (b) optical 
absorption of 4.8, 12.1, 27.3, and 46.6 nm PEG-
coated gold NPs.  
 
3.2. Blood plasma stability of the PEG-coated 
gold NPs 
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To investigate the stability of human blood 
plasma treated by the PEG-coated gold NPs, the 
time-dependent SPR peak location and intensity 
of the PEG-coated gold NPs in human blood 
plasma have been investigated (Figure 2 (a)). The 
intensity of SPR peak gradually decreases for all 
sizes of the PEG-coated gold NPs with increasing 
time. The decreased intensity of SPR peak is 
related to the structure and optical properties of 
the PEG-coated gold NPs, which indicates that 
the PEG-coated gold NPs combine with the 
proteins in blood plasma and form larger 
compounds. A slight redshift about 3-5 nm of 
SPR peak location is observed in all sizes of the 
PEG-coated gold NPs. This shift indicates that 
the PEG-coated gold NPs aggregate slightly in 
solution, but the SPR peak location has gradually 
stabilized and has no shift after 6 h. The 
gradually stabilized SPR peak indicates that the 
PEG-coated gold NPs can be stabilized. It is well 
known that the naked and citrate coated gold NPs 
have high ζ potentials, and they prefer to 
aggregate in the physiological environment. It has 
been shown that the naked gold NPs can induce 
the formation of protein-based aggregation at 
physiological pH, and this structure is a 
compound of networks of gold NPs and protein 
[23, 29]. PEG-coating can improve the surface 
properties of gold NPs [30]. However, it can be 
conceived that many serum proteins in the 
medium can cause the degradation of PEG 
coating, and form small range aggregation of 
several particles. In the processing of cellular 
uptake, the size of the PEG-coated gold NPs can 
mediate receptor-ligand binding constants, 
receptor recycling rates, and exocytosis [31]. To 
directly observe the distribution of the PEG-
coated gold NPs in HeLa cell, we have performed 
TEM observations. 
TEM images show microscopic observation 
into the distribution of 4.8, 12.1, 27.3, and 46.6 
nm PEG-coated gold NPs in HeLa cells in Figure 
2 (b). After 12 hours cellar uptake, 4.8 nm PEG-
coated gold NPs show a bubble aggregation in 
the cell membrane. Moreover, the PEG-coated 
gold NPs have local distribution hybrided with 
biomolecules, which indicates that in vitro 
distribution of 4.8 nm PEG-coated gold NPs is 
not well monodispersed in the medium and HeLa 
cell. The complex compounds, including the 
biomolecules and gold, can be found in the 
medium. Recently, Oh et al. also found that 5.5 
nm PEG-coated gold NPs could be observed in 
the membrane, which is in good agreement with 
our results [32]. As a contrast, 12.1 nm PEG-
coated gold NPs has a wide distribution in 
intracellular and extracellular areas, which is 
consistent with the previous results [9]. 12.1 and 
 
27.3 nm PEG-coated gold NPs slightly aggregate 
by several particles and form larger size of 35-60 
nm, which is in agreement with the results of 
blood plasma stability. 46.6 nm PEG-coated gold 
NPs can also form larger size hybrid compounds. 
However, the overall numbers of these particles 
are very small compared with the data of 12.1 
and 27.3 nm particles. 
 
Figure 2. Plasma stability of the PEG-coated 
gold NPs in the human blood plasma have been 
tested using time-dependent optical absorption. 
(a)Time-dependent SPR optical absorption and (b) 
in vitro biodistribution of the PEG-coated gold 
NPs are presented.  
 
3.3. Size-dependent in vitro cytotoxicity  
The evaluation of cytotoxic effects induced by 
the PEG-coated gold NPs is performed. After 24 
and 48 hours, the viabilities of the cells treated by 
4.8, 12.1, 27.3, and 46.6 nm PEG-coated gold 
NPs are presented at different concentrations of 
0.005-0.25 mM in Figures 3 (a) and (b). In 
general, there is a decrease in cellular viability in 
a concentration-dependent manner, which 
indicates that the cytotoxic effects of all sizes of 
the PEG-coated gold NPs increase in a clear 
concentration-dependent manner. These data are 
in agreement with widely reported investigations 
where the safe dose of the PEG-coated gold NPs 
was about 10-4 M [7, 33]. After 24 hour 
treatments, 4.8 nm PEG-coated gold NPs show 
the highest toxicity, and cellular viability sharply 
decreases to 50% above 0.25 mM. The viabilities 
of the cells treated by 12.1 and 27.3 nm PEG-
coated gold NPs also decrease to 60% at the dose 
of 0.25 mM, but 46.6 nm PEG-coated gold NPs 
show cellular viability of 90% even at the dose of 
0.25 mM. After further treatment of 48 hours, it 
is found that the viabilities of the cells treated by 
12.1 and 27.3 nm PEG-coated gold NPs at 0.25 
mM have recovered to 75% and 76%, 
respectively. However, the cell viability treated 
by 4.8 nm PEG-coated gold NPs further 
decreases to 43% at the dose of 0.25 mM, while 
viability of 83% is observed in cells treated by 
46.6 nm PEG-coated gold NPs. By analyzing the 
dose–response curve, IC50 of 4.8, 12.1, 27.3, and 
46.6 nm PEG-coated gold NPs after 48 hours are 
0.205, 0.477, 0.448, and 0.613 mM, respectively. 
It can be determined that 46.6 nm PEG-coated 
gold NPs have the best biocompatibility. 12.1 and 
27.3 nm PEG-coated gold NPs have low toxicity 
while 4.8 nm PEG-coated gold NPs show the 
highest toxicity. Size-dependent in vitro 
cytotoxicity of the PEG-coated gold NPs has 
been well documented and it is generally 
accepted that the smaller a particle is, the greater 
the toxicity is. 
The cytotoxicity of nanomaterials depends on 
many factors [6]. It is well known that size and 
surface chemistry of NPs can induce different in 
vitro toxicity effects. It was found that 1.2 and 
1.4 nm gold clusters had higher cytotoxicity than 
15 nm gold particles by cell necrosis and 
apoptosis, and modified gold NPs seem closely 
related to size instead of ligand chemistry [7, 34]. 
Indeed, 18 nm gold NPs were nontoxic and 
surface modifiers showed cytotoxicity, while 33 
nm gold NPs were found to be low toxicity in 
different cell lines [34]. This cytotoxicity could 
be related to the electrostatic adsorption between 
the cationic NPs and the negatively charged cell 
membranes. After modification by PEG-SH, gold 
NPs have lower cytotoxicity and wider cell 
uptake, which can provide valuable information 
for further surface modification of therapeutic 
NPs. For large size of gold NPs, uptake into 
HeLa cells demonstrats that 46.6 nm PEG-coated 
gold NPs are nontoxic up to 1 mM. Naked 50 nm 
gold particles were taken up more quickly by the 
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cells than smaller and larger NPs [31]. Next, we 
move to in vitro and in vivo radiotherapy of the 
PEG-coated gold NPs. 
 
Figure 3. Concentration-dependent in vitro 
toxicity of 4.8, 12.1, 27.3, and 46.6 nm PEG-
coated gold NPs after (a) 24 and (b) 48 h. The 
results show that the smaller particles have a 
higher toxicity. 
 
3.4. Size-dependent in vitro radiation therapy 
Because gold NPs have shown promise as X-
ray contrast agents and radiosensitizers in cancer 
therapy, we tested in vitro radiosensitization 
effects of the PEG-coated gold NPs in HeLa cells. 
HeLa cells were treated with PBS control and 
PEG-coated gold NPs with different sizes at the 
concentrations of 0.05 and 0.1 mM for 24 hours. 
Subsequently, the cells were irradiated with 0, 2, 
4, 6, and 8 Gy of ionizing radiation, and then 
rinsed and subjected to clonogenic assays.  
 
Figure 4. Cloning formations of 4.8, 12.1, 27.3, 
and 46.6 nm PEG-coated gold NPs at the 
concentrations of (a) 0.05 mM and (b) 0.1 mM 
using 137Cs with 662 keV. (c) Cell apoptosis of 
4.8, 12.1, 27.3, and 46.6 nm PEG-coated gold 
NPs after 2 Gy radiation. 12.1 nm PEG-coated 
gold NPs have the strongest radiation 
enhancement effect by cellar apoptosis and 
necrosis. 
 
The radiation dose-dependent radiosensitizing 
effects of all sizes of the PEG-coated gold NPs 
(0.05 mM) have been shown in Figure 4 (a). 
After normalizing survival curves, the surviving 
fraction decreases, and there is a significant 
separation of the curves compared with that of 
radiation alone (P < 0.05). 12.1 nm PEG-coated 
gold NPs perform the strongest radiation 
enhancement effect among the four kinds of 
particles. 27.3 nm PEG-coated gold NPs also 
shows high enhancement of radiation effect. 
Furthermore, to evaluate the enhancement 
efficiency, the SER is calculated. It can be found 
that the SER of 4.8, 12.1, 27.3, and 46.6 nm 
PEG-coated gold NPs are 1.41, 1.65, 1.58, and 
1.42 respectively, at the concentration of 0.05 
mM. It can be found that the size increase of the 
PEG-coated gold NPs can not increase the 
radiation sensitivity of HeLa cells. To obtain 
repeatability, we also carried out experiments to 
understand the size-dependent radiosensitization 
effects of the PEG-coated gold NPs at the high 
concentration of 0.1 mM. As shown in Figure 4 
(b), 12.1 and 27.3 nm PEG-coated gold NPs 
7
 
cause higher growth inhibition after 8 Gy 
radiation than the only radiation group. The 
calculated SER are 1.46, 2.07, 1.86, and 1.52, 
corresponding to 4.8, 12.1, 27.3, and 46.6 nm 
PEG-coated gold NPs, respectively. The results 
indicate that 12.1 and 27.3 nm PEG-coated gold 
NPs can effectively sensitize HeLa cells by 
radiation. To further confirm these results and 
reveal the radiosensitivity mechanism, the cell 
apoptosis of the PEG-coated gold NPs was 
carried out. 
 
Figure 5. (a) Tumor growth curves and (b) tumor 
weights of 4.8, 12.1, 27.3, and 46.6 nm PEG-
coated gold NPs treated mice at the concentration 
of 4 mg/kg. Bars represent mean ± standard 
deviation. Data are analyzed by Student’s t-test, 
and *, P < 0.05; **, P < 0.01; ***, P < 0.001. 
12.1 nm PEG-coated gold NPs have the most 
significant decrease of tumor size, and 27.3 nm 
followed. 4.8 and 46.6 nm PEG-coated gold NPs 
have the weakest enhancement effects.  
The size-dependent cell apoptosis of four kinds 
of gold NPs at the concentration of 0.1 mM is 
presented in Figure 4 (c). To estimate whether the 
PEG-coated gold NPs cause preferentially 
apoptotic or necrotic cell death, we treat HeLa 
cells in the logarithmic growth phase with the 
toxicity groups including control, 4.8, 12.1, 27.3, 
and 46.6 nm PEG-coated gold NPs. We also treat 
them with 2 Gy radiation including radiation, 4.8 
nm + radiation, 12.1 nm + radiation, 27.3 nm + 
radiation, and 46.6 nm + radiation PEG-coated 
gold NPs groups. It can be observed that control 
group remains 94.44% live, and apoptotic and 
necrotic cells constitute only 4.39%. For the toxic 
groups (no-radiation), apoptosis ratios are 7.77%, 
1.55%, 5.34%, and 3.09%, corresponding to 4.8, 
12.1, 27.3, and 46.6 nm PEG-coated gold NPs, 
respectively. 4.8 nm PEG-coated gold NPs show 
slight toxicity by apoptosis, and 12.1, 27.3, and 
46.6 nm PEG-coated gold NPs perform tiny cell 
apoptosis. These results are in agreement with 
toxicity results. Similar cell apoptosis of 1.4 nm 
gold clusters was observed, which further 
confirmed that small gold NPs were more toxic 
than large gold NPs [34]. To further investigate 
the radiation sensitivity of PEG-coated gold NPs, 
apoptosis of cell treated by 4.8, 12.1, 27.3, and 
46.6 nm PEG-coated gold NPs + 2 Gy radiation 
are recorded. Apoptosis ratios induced by 
radiation are 7.65%, 21.86%, 11.19%, and 3.77%, 
corresponding to 4.8, 12.1, 27.3, and 46.6 nm 
particles + 2 Gy radiation treated, respectively. 
Meanwhile, necrotic cell ratios induced by 
radiation are 6.13%, 15.59%, 6.93%, and 1.09% 
for 4.8, 12.1, 27.3, and 46.6 nm particles + 2 Gy 
radiation treated, respectively. These results 
indicate that the radiation enhancement effects of 
12.1 and 27.3 nm PEG-coated gold NPs can be 
caused by both rapid cell necrosis and subsequent 
apoptosis. Meanwhile, the main enhancement 
effects of 4.8 and 46.6 nm PEG-coated gold NPs 
are rapid cell necrosis. In general, it can be 
determined that 12.1 nm PEG-coated gold NPs 
has the strongest radiation sensitivity among 
these particles. This can effectively explain the 
survival fraction from the cloning formation. 
Indeed, it was found that 10-20 nm PEG-coated 
gold NPs had a higher efficiency in endocytosis 
than 45 or 60 nm PEG-caoted gold NPs. 
Meanwhile, 5 nm gold NPs coated by PEG rarely 
participated in endocytosis, which was different 
from the activity of the naked gold NPs [35]. The 
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Xia group also found that the PEG-modified Au 
nanostructures could hardly adhere to the cell 
membrane, so their adsorption rate by the cells 
was very low. Further, the cells had a 1.5–2.4 
times higher uptake for the 15 nm NPs than for 
the 45 nm NPs, which was quite different from 
the performance of the naked gold particles [36]. 
Therefore, 12.1 and 27.3 nm particles show 
higher radiation enhancements than other sizes 
particles. To test the viability of these results, in 
vivo radiosensitization was carried out. 
3.5. Size-dependent in vivo radiation therapy 
9
We show in vivo cancer treatment by the PEG-
coated gold NPs in the U14 mice cancer model in 
Figure 5. Actually, in vitro cultures can’t 
replicate the complexity of an in vivo system or 
provide exact data about the response of a 
physiologic system to gold NPs. The enhanced in 
vivo radiotherapy is determined by many 
parameters, including dose, route of exposure, 
metabolism, excretion, and immune response. 
Female and male BALB/c mice bearing 
subcutaneous inoculated U14 tumors were treated 
by different sizes of the PEG-coated gold NPs 
over 24 days. The mice were observed daily for 
clinical symptoms, and the tumor volume was 
measured by a caliper in tumor-bearing mice. A 
time-related increase in tumor volume is 
observed in the control untreated group, 4.8, 12.1, 
27.3, and 46.6 nm group, in which the tumors 
show average volumes of 668.4, 492.3, 604.6, 
524.6, and 452.8 mm3, respectively (Figure 5 (a)). 
The slightly decreased tumor size induced by 4.8, 
12.1, 27.3, and 46.6 nm PEG-coated gold NPs 
can be observed. This represents tumor growth 
inhibition, but there is no significant statistical 
difference in inhibition when compared with the 
control group. After receiving 5 Gy gamma 
radiation, tumor volumes are significantly 
decreased. It is found that average tumor volumes 
are 394.4 (P=0.18 versus control), 349.6 mm3 
(P=0.06 versus control), 37.1 (P＜0.001 versus 
control), 130.3 (P＜ 0.01 versus control), and 
290.4 mm3 (P ＜ 0.05 versus control) for the 
radiation, 4.8 nm + radiation, 12.1 nm + radiation, 
27.3 nm + radiation, and 46.6 nm + radiation 
PEG-coated gold NPs groups, respectively (24 
days). This represents enhanced tumor growth 
inhibition. 12.1 nm PEG-coated gold NPs show 
the most significant radiation enhancement effect, 
and 46.6 nm PEG-coated gold NPs show the 
lowest enhancement effect. The tumor weights of 
mice after 24 days are shown in Figure 5 (b). The 
tumor weights of control, 4.8, 12.1, 27.3, and 
46.6 nm PEG-coated gold NPs groups are 1.27, 
1.21, 1.24, 0.93, and 0.71 g, respectively. After 5 
Gy radiation, the tumor weights decrease to 0.68, 
0.53, 0.046 (P＜0.001 versus radiation), 0.33 (P
＜0.01 versus radiation), and 0.49 g (P＜0.05 
versus radiation), corresponding to radiation, 4.8 
nm + radiation, 12.1 nm + radiation, 27.3 nm + 
radiation, and 46.6 nm + radiation groups, 
respectively. The tumor weights of mice treated 
by 12.1 nm PEG-coated gold NPs sharply 
decrease and nearly disappear after 24 days. 
Treatment by 27.3 nm PEG-coated gold NPs also 
leads to a significant decrease. However, 46.6 nm 
PEG-coated gold NPs has a minimal decrease 
compared with alone radiation group. These in 
vivo results further confirm that 12.1 nm PEG-
coated gold NPs has the greatest radiation 
enhancement effect. 
 
3.6. Biodistribution 
 
Figure 6. Biodistributions of 4.8, 12.1, 27.3, and 
46.6 nm PEG-coated gold NPs treated mice after 
24 days treatment. 12.1 and 27.3 nm PEG-coated 
gold NPs have higher content in tumor than that 
of 4.8 and 46.6 nm PEG-coated gold NPs.  
 
Figure 6 gives biodistributions of the PEG-
coated gold NPs in blood and bone marrow cells 
after intraperitoneal administration at the dose of 
4 mg/kg (24 days). Biodistribution shows that 
liver and spleen are the main target organs, which 
are in good agreement with the previous results 
[10, 26, 37]. 4.8 nm PEG-coated gold NPs have a 
wider distribution in all organs, and 12.1 nm 
 
PEG-coated gold NPs mainly distribute in liver. 
27.3 nm NPs prefer to stay in spleen and 46.6 nm 
NPs have little distribution in all organs. It is 
notable that 12.1 nm NPs have the highest 
content in tumor, followed by 27.3 nm NPs. As a 
contrast, 4.8 and 46.6 nm PEG-coated gold NPs 
have very tiny accumulation in the tumors. This 
gives a robust support to in vivo therapy results. 
In available in vivo experiments, it was found that 
12.1 nm PEG-coated gold particles could rapidly 
diffuse throughout the tumor matrix, while 45 nm 
PEG-coated gold particles could only stay near 
the vasculature [38]. This result indicated long 
blood circulation time of gold NPs, which was in 
agreement with the previous reports [37]. 
 
Figure 7. (a) Body weight, (b) spleen index, and 
(c) thymus index of 4.8, 12.1, 27.3, and 46.6 nm 
PEG-coated gold NPs treated mice at the 
concentration of 4 mg/kg. Bars represent mean ± 
standard deviation. Data are analyzed by 
Student’s t-test, and no significant difference 
from the control group (p < 0.05) is observed. 
10
 
From the viewpoint of radiation physics, the 
dominant radiation damage of gold NPs can be 
caused by photoelectric absorption and secondary 
electron. The high energy gamma has a strong 
penetration, and gold NPs of different sizes have 
nearly similar damage effects and negligible 
differences of radiation enhancement effect on 
can only have a 1-30 nm projected range, which 
determines the size-dependent protein and DNA 
damages. Indeed, it was found that gold NPs 
could enhance degradation of DNA under a high 
energy ray. There was also a powerful evidence 
which showed that strand break of DNA could be 
induced by gold NPs [39]. Besides, distribution 
and number of the PEG-coated gold NPs in the 
tumor will play a very important role in the 
radiosensitization. 12.1 and 27.3 nm PEG-coated 
gold NPs have wide distributions and an 
appreciable number in tumor, and cause the 
massive radiation damage. Therefore, it is not 
difficult to understand why 12.1 nm PEG-coated 
gold NPs have the highest enhancement effect, 
and 4.8 nm PEG-coated gold NPs show 
negligible radiation enhancement. Increasing size 
has not induced an enhancement of radiation 
effect. 
3.7. In v
the HeLa cell. But secondary electron of 0-50 eV 
ivo toxicity: Pathological, Immune 
system, and Biochemistry 
 
Figure 8.  Pathological results from the liver, 
Toxic side effects of gold NPs to normal organs 
an
spleen, and kidney of 4.8, 12.1, 27.3, and 46.6 nm 
PEG-coated gold NPs treated mice at the 
concentration of 4 mg/kg. All these organs don’t 
show appreciable pathological changes except for 
liver. 
 
d to overall well-being have been the main 
problems resulting from cancer radiotherapy and 
drug delivery. Figure 7 shows (a) body weight, (b) 
spleen index, and (c) thymus index results. We 
observe neither considerable body weight loss 
nor mortality variation in all treated mice (Figure 
 
Figure 9. Blood biochemistry results of 4.8, 12.1, 
27.3, and 46.6 nm PEG-coated gold NPs treated 
mice after 24 days. These results show mean and 
standard deviation of (a) ALT, (b) AST, (c) 
albumin, and (d) globulin. Data are analyzed by 
Student’s t-test, and the significant difference 
from the control group (p < 0.05) is observed. 
The increases of ALT and ALS indicate that the 
liver function has been affected by 12.1, 27.3, 
and 46.6 nm PEG-coated gold NPs.  
 
Further, a blood chemistry test was performed 
after 24 days of initiation treatment. Specific 
is phenomenon. 13 nm gold particles coated by 
PEG could induce abnormal gene expression and 
ac
7 (a)). We perform spleen index (Figure 7 (b)) 
and thymus index (Figure 7 (c)) to examine 
immune system damage induced by the PEG-
coated gold NPs in mice. The average values of 
thymus and spleen indices in the control group 
are 2.39 and 6.8, respectively. High spleen index 
indicates the immune response of mice, which 
has been widely reported [40]. After 4.8, 12.1, 
27.3, and 46.6 nm PEG-coated gold NPs treated, 
spleen indices of mice change to 7.1, 4.6, 6.2, and 
6.3, respectively. Radiation induces further 
change to 4.5, 7.1, 4.2, 4.3, and 4.6, 
corresponding to radiation, 4.8 nm + radiation, 
12.1 nm + radiation, 27.3 nm + radiation, and 
46.6 nm + radiation group, respectively. Thymus 
indices of 4.8, 12.1, 27.3, and 46.6 nm PEG-
coated gold NPs non-irradiated group increase to 
2.8, 2.99, 2.58, and 2.74, respectively. Thymus 
indices of radiation group, 4.8, 12.1, 27.3, and 
46.6 nm PEG-coated gold NPs radiation group 
are 2.2, 2.8, 2.72, 2.52, and 2.4, respectively. 
However, it has no significant difference. 12.1 
nm PEG-coated gold NPs after 5 Gy radiation 
show the lowest spleen index, which is consistent 
with the decrease of tumor volume. Besides, 
biodistribution of the PEG-coated gold NPs can 
also influence the organ index. Liver and spleen 
are considered as two dominant organs for 
biodistribution and metabolism of the PEG-
coated gold NPs. 12.1, 27.3, and 46.6 nm PEG-
coated gold NPs have no significant effects on 
the immune system. Figure 8 presents 
pathological results for liver, spleen, and kidney. 
No significant abnormal damages are observed in 
kidney and spleen. However, liver damage can be 
seen in mice treated by all sizes of the PEG-
coated gold NPs from pathological results. 
 
attention was paid to those hepatic-related serum 
chemistries that would reflect liver damage or 
alternation of liver function. It is found that 12.1, 
27.3, and 46.6 nm PEG-coated gold NPs, 
including radiation and non-radiation, can cause 
the increases of aspartate aminotransferase (AST) 
and alanine transaminase (ALT) in Figure 9. For 
alone radiation group, ALT also increases. 
Besides, albumin (ALB) and globulin (GLOB) 
are found to have no significant statistical 
difference. Indeed, it is not difficult to understand 
th
cumulation in liver [8, 10, 41]. In spite of 
reducing the toxicity of gold NPs by PEG coating, 
the biodistribution of 13 nm PEG-coated gold 
particles showed long retention in liver [8, 10]. 
These results showed that further metabolism of 
gold based materials must be investigated. In vivo 
toxicity and biodistribution show that the PEG-
coated gold NPs are different from the naked 
gold NPs. 12.1 nm PEG-coated gold NPs have a 
higher efficient diffusion and absorption for 
tumors and can further mediate tumor targeting 
efficiency. Naked gold NPs strongly associated 
with these essential blood proteins (such as 
albumin, fibrinogen, γ-globulin, histone, and 
insulin), and the degree of binding between NPs 
and proteins was related to the NPs size [29, 42]. 
Furthermore, these interactions, such as enhanced 
binding and whether they can induce 
conformational change of the proteins, should be 
further investigated. It would be interesting to 
fabricate the tumor targeting bioconjunction 
based on 12.1 and 27.3 nm PEG-coated gold NPs, 
and to investigate in vitro and in vivo targeting 
radiotherapy. Meanwhile, whether these 
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therapeutic particles in liver or kidney can be 
metabolized by the bioactive environment if the 
therapy time is above 6 mouths is a very 
important question for future clinical therapy. It 
is desirable to find an available route to improve 
metabolism of the PEG-coated gold NPs. Most 
recently, we have found the GSH-protected gold 
nanoclusters perform high-efficient renal 
clearance, and the enhancement of radiation 
therapy of these small nanoclusters will be very 
interesting [43]. 
4. Conclusion  
Size-dependent in vitro and in vivo 
radiosensitizations of the PEG-coated gold NPs 
were carried out. Toxicity, survival fraction, 
apoptosis, and morphology of HeLa cell were 
investigated at different concentrations. In vitro 
toxicity results showed that small NPs had higher 
toxicity than that of large NPs. Further, 12.1 and 
27.3 nm PEG-coated NPs had wider distributions 
in the cells and performed higher radiation 
enhancement effects than that of 4.8 and 46.6 nm 
NPs. It was found that 4.8 and 46.6 nm PEG-
coated gold NPs caused predominantly rapid cell 
12
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death by apoptosis, while 12.1 and 27.3 nm PEG-
coated gold NPs induced enhancement of 
radiotherapy by both necrosis and apoptosis. In 
vivo cancer treatments also showed that all sizes 
of PEG-coated gold NPs could decrease the 
tumor volume and weight after 5 Gy radiation, 
but 12.1 and 27.3 nm PEG-coated gold NPs could 
induce appreciable decrease of tumor volume and 
weight. Immune response and blood biochemistry 
from in vivo toxicity indicated that the PEG-
coated gold NPs did not cause appreciable 
toxicity except for the slight liver damage. Based 
on in vitro and in vivo radiation therapy, it can be 
conceived that 12.1 and 27.3 nm PEG-coated 
gold NPs show high radiosensitivity and thus are 
valuable for possible applications in enhancement 
of radiotherapy and drug delivery.  
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